ZEVRA THERAPEUTICS, INC. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Zevra Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Zevra Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -168 %, a 426% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Return On Equity for 2023 was -76.3 %, a 177% decline from 2022.
  • Zevra Therapeutics, Inc. annual Return On Equity for 2022 was -27.5 %, a 260% decline from 2021.
  • Zevra Therapeutics, Inc. annual Return On Equity for 2021 was -7.63 %, a 139% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -76.3 -48.8 -177% Jan 1, 2023 Dec 31, 2023
2022 -27.5 -19.9 -260% Jan 1, 2022 Dec 31, 2022
2021 -7.63 -27.2 -139% Jan 1, 2021 Dec 31, 2021
2020 19.6 -12.9 -39.7% Jan 1, 2020 Dec 31, 2020
2019 32.5 -36.9 -53.2% Jan 1, 2019 Dec 31, 2019
2018 69.5 -27.6 -28.4% Jan 1, 2018 Dec 31, 2018
2017 97.1 -69.6 -41.8% Jan 1, 2017 Dec 31, 2017
2016 167 -161 -49.1% Jan 1, 2016 Dec 31, 2016
2015 328 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.